fbpx
Spotlight On: Lung Cancer Treatment

 

The American Cancer Society estimates lung cancer will be detected in nearly 220,000 people this year. The disease, ranked as the most common cancer diagnosis worldwide, kills more people annually than breast, colon and pancreatic cancers combined. While surgery or external-beam radiation therapy is considered a standard treatment for lung cancer, patients who are in […]

 

Learn More

 

 

Philadelphia CyberKnife Marks Seven Years On Cutting Edge of Cancer Treatment and Research

 

This month, Philadelphia CyberKnife celebrates its seventh year of operations as a service of Delaware County Memorial Hospital, part of the Crozer-Keystone Health System. Our center was the first provider of stereotactic radiosurgery (SRS) treatment in the Philadelphia region, and we’ve treated nearly 2,000 patients with the advanced procedure using CyberKnife® technology.  Through research spearheaded […]

 

Learn More

 

 

Get to Know: Dr. John Lamond

 

Dr. John Lamond, associate medical director of Philadelphia CyberKnife, has more than 20 years of experience treating tumors throughout the body. As an active clinical researcher, Dr. Lamond has special interests in brain and lung cancers and has served as the principal investigator on several studies. Read about results from a recent study he co-authored […]

 

Learn More

 

 

New Philadelphia CyberKnife Study Shows SBRT Effective for Prostate Cancer Treatment

 

Newly published research from Philadelphia CyberKnife provides some of the most convincing evidence yet that stereotactic body radiation therapy is among the most effective types of treatment for prostate cancer.

Authors say that, while more follow-up is needed, the study shows SBRT’s success rate is comparable to other treatments, including conventional surgery, which is often held as the gold standard treatment for prostate cancer. In addition, SBRT offered more convenient treatment and less risk of side effects like erectile dysfunction.

“Radiation oncologists believe the results with SBRT are equivalent to what you’d get from surgery or other forms of radiation, but there’s never been a head-to-head comparison,” says Dr. Rachelle Lanciano, chief of radiation oncology at Delaware County Memorial Hospital, who co-wrote the study. “This is another piece of the puzzle showing that SBRT works, the toxicity is low, and the outcomes are very good.”

 

Learn More

 

 

Philadelphia CyberKnife Continues Trailblazing Cancer Research

 

Philadelphia CyberKnife physicians are set this week to present innovative research findings demonstrating the effectiveness of stereotactic body radiation therapy for treating primary and recurrent lung cancer.

Two studies will be presented Feb. 22 at the Radiosurgery Society’s 2013 SRS/SBRT Scientific Meeting in California. These are the latest studies from Philadelphia CyberKnife, which has carved a niche for trailblazing clinical research focused on stereotactic body radiation therapy. CyberKnife® is a robotic technology that provides stereotactic body radiation therapy, or SBRT, a noninvasive method of treating tumors with very precise, high-dose radiation beams in five or fewer procedures.

 

Learn More

 

 

Lung Cancer Awareness Important for Prevention, Early Detection

 

As the second-most common cancer in both men and women, lung cancer is responsible for the majority of cancer-related deaths. The American Cancer Society estimates more than 160,000 people will lose their battle with lung cancer this year, accounting for more victims than breast, prostate, colon and pancreatic cancers combined. In recognition of National Lung […]

 

Learn More

 

 

Breast Cancer Awareness: Treatment Options When Breast Cancer Spreads

 

As the second-most diagnosed cancer in women in the U.S., it’s tough to find someone who hasn’t been impacted by breast cancer in some way. The American Cancer Society estimates 230,480 women will be diagnosed with invasive breast cancer this year. When breast cancer is discovered after it starts causing symptoms, the cancer is likely […]

 

Learn More

 

 

Philadelphia CyberKnife Credentialed by Radiological Physics Center

 

Philadelphia CyberKnife has been credentialed by the Radiological Physics Center (RPC), an organization funded by the National Cancer Institute (NCI) to provide quality assurance auditing of dosimetry practices at institutions participating in NCI cooperative clinical trials. The RPC assures the NCI and cooperative clinical trial groups that all participating institutions have the equipment, personnel and […]

 

Learn More

 

 

Philadelphia CyberKnife Celebrates Patient Safety Awareness Week

 

In recognition of Patient Safety Awareness Week, Philadelphia CyberKnife joins a nation-wide effort to encourage engagement of patients, families and the community by promoting the importance of being an active participant in the health care delivery process.

 

Learn More